Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 211Thoracic 72Head & Neck 25Other solid neoplasm 14Gynecologic 13Lymphoid 10Breast 8Tumor-Agnostic 7CNS 6Sarcoma 4Genitourinary 4Endocrine 3Other neoplasm 2NET 2Dermatologic 2Myeloid 1

Conditions

Salivary Gland Malignant Neoplasms 1Precancerous Conditions 1Mouth Neoplasms 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × sintilimab × Other neoplasm × Clear all
NCT05000892 2022-12-02

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

NCT04065737 2019-08-22

STOP

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Unknown
29 enrolled
Head & NeckOther neoplasm

Mouth Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡